The invention herein is related to the use of Lactobacillus reuteri strains as immune enhancing agents, methods of improving immune-function in mammals using Lactobacillus reuteri strains in products containing cells of such strains and the products as such.. These strains exhibit good toxin binding ...
21 of 22 subjects completed the study without protocol violation (mean age 52years; 36% men). L. reuteri plus pantoprazole twice a day cured 13.6% (3/22; 95% CI 2.9–34.9%) of patients with H. pylori infection by ITT analysis and 14.2% (3/21; 95% CI 3.0–36%) by PP analysis....
This randomized clinical trial examines the use of Limosilactobacillus reuteri supplementation in early postmenopausal women for the prevention of bone
In RA patients, the oral administration ofL. rhamnosusandL. reuterifor 3months promoted an improvement in theHealth Assessment Questionnairescore with functional improvement[70]. Another trial revealed improvement indisease activity score, increased levels of serum IL-10, and lower levels of proinflammat...
reuteri) and a gut microbiota-derived metabolite propionate, which specifically responded to CQA treatment to promote adipose browning and thereby energy expenditure. Our current findings suggest a novel synergistic “probiotics-prebiotics” therapeutic strategy for the treatment of obesity and its ...
reuteri DSM 17938 were washed three times with sterile normal saline and resuspended to a concentration of 3 × 109 colony-forming units (CFU)/mL for further use. 2.2. Experimental design and sample collection Twenty-four male specific pathogen-free (SPF) Sprague-Dawley rats (Shanghai SLAC ...
reuteri and GOS9. To study the impact of a synbiotic consisting of GOS and L. reuteri on intestinal inflammation and barrier function, we administered GOS and L. reuteri separately or in combination to mice for four weeks, followed by DSS treatment for another week (Fig. 1a). The results ...
Ligilactobacillus salivarius is a lactic acid bacteria that has been gaining attention as a promising probiotic. Numerous strains exhibit functional proper
L. reuteri DSM 17938, L. reuteri ATCC PTA6475, and a high-dose proton pump inhibitors (PPI)–bismuth-containing quadruple therapy resulted in an excellent cure rate for H. pylori infection as first-line treatment irrespective of CYP2C19 and antibiotic resistance pattern (Poonyam, Chotivitayatara...
, 2003). Genome sequencing may facilitate future research on probiotic strains, for instance by microarray experiments. Finally, some heterofermentative lactobacilli as part of the normal microbial population of the human GIT have been identified as well, which include mainly Lactobacillus reuteri and,...